IR-Med (IRME) Shares Outstanding (Diluted Average) (2022 - 2025)
IR-Med recorded quarterly Shares Outstanding (Diluted Average) of $72.4 million in Q2 2025, up 1.64% quarter-over-quarter from $71.3 million in Q1 2025, and up 3.05% year-over-year from $70.3 million in Q2 2024.
IR-Med's Shares Outstanding (Diluted Average) history runs 4 years deep, the most recent figure standing at $72.4 million for Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | IR-Med | - | - | - | 72.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 72.42 Mn |
| Mar 31, 2025 | 71.26 Mn |
| Sep 30, 2024 | 70.76 Mn |
| Jun 30, 2024 | 70.28 Mn |
| Mar 31, 2024 | 69.93 Mn |
| Sep 30, 2023 | 69.23 Mn |
| Jun 30, 2023 | 68.92 Mn |
| Mar 31, 2023 | 68.83 Mn |
| Sep 30, 2022 | 68.72 Mn |